CT HB07192

Pharmacy benefits managers must exercise good faith and fair dealing with health carriers, disclose conflicts of interest in writing, and offer health plans the option to be charged the same drug price they pay pharmacies (effective October 1, 2025 and January 1, 2026)

Establishes a task force to study prescription drug shortage preparedness and allows the Commissioner of Economic and Community Development to use bond proceeds to support in-state prescription drug production capacity

Creates a framework for a Canadian prescription drug importation program, requiring a feasibility study by October 1, 2027, with potential FDA approval sought under Section 804 of the federal Food, Drug and Cosmetic Act

Requires the Department of Administrative Services to negotiate bulk prescription drug prices on behalf of state agencies and establishes an Advisory Council on Pharmaceutical Procurement, with authority to enter multi-state compacts for increased purchasing power

Mandates the Commissioner of Social Services petition federal authorities to authorize generic GLP-1 drugs for obesity and diabetes treatment for HUSKY Health program members, and requires health insurers to credit out-of-pocket prescription drug payments toward deductibles when patients pay less than in-network rates